Voltage-dependent T-type Ca2+ channels have eminent roles in sperm function. In the present study, we investigated the effects of raloxifene, a selective estrogen receptor modulator, on T-type Ca2+ channels in mouse spermatogenic cells by using both electrophysiological and molecular techniques. We found that T-type calcium currents (IT-Ca) were inhibited by raloxifene in a concentration-dependent manner with an IC50 of 2.97 µM, as assessed with the patch clamp technique. Application of raloxifene at 2 µM inhibited IT-Ca by 54.9 ± 2.1% at –20 mV (n = 10, p < 0.05). Furthermore, raloxifene-induced inhibition of IT-Ca was associated with a negative shift of both the activation and the steady-state inactivation properties. The time constants of activation and inactivation were decreased, the time constant of deactivation was increased, but the time constant of recovery was not affected. In addition, the inhibitory effects of raloxifene and 17β-estradiol on IT-Ca were unaffected by the estrogen receptor antagonist ICI 182,780. We also found that raloxifene treatment decreased the mRNA expression of CaV3.2 and CaV3.3, but not CaV3.1 in GC-2spd (ts) cells (mouse spermatocyte cell line), as assessed by real-time RT-PCR. Taken together, these data indicate that in mouse spermatogenic cells, raloxifene decreases IT-Ca independent of classical estrogen, and the mRNA expression of T-type calcium channels and therefore may affect male reproductive function.

Keywords:
Patch clamp, Raloxifene, Reverse transcriptase polymerase chain reaction, Spermatogenic cells, Voltage-dependent T-type Ca2+ channels
This content is only available via PDF.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.